How can I predict toxicity in drug discovery?
The importance of predicting toxicity early in drug development Highlighting safety and toxicity early in the drug development process is…
Summary
This article explores the psychological barriers and risks of cognitive biases to R&D decision-making. It contrasts current practice with the use of evidence-based medicine by healthcare practitioners. It touches on how computational tools, such as StarDrop‘s integrated suite of discovery software, can help support good decision making in drug discovery.
Citation details
A. T. Chadwick and M. D. Segall, Drug Discovery Today, 2010, 15 (13/14), pp. 561-569.
DOI: 10.1016/j.drudis.2010.05.007
Find out more
For more information on how to use computational tools to support good discovery decisions, explore our StarDrop webpage.
More resources
Why don’t my QSAR models work?
Why QSAR models matter in drug discovery Before we start troubleshooting, let’s remember why we build and run these models…
Leveraging structure-based and ligand-based techniques in drug discovery
In our recent article in Innovations in Pharmaceutical Technology, we explore the principles, techniques, and applications of structure-based and ligand-based…
